Abstract
Esophageal cancer has a very dynamic global epidemiology with wide variations from region to region. Males from Eastern Asia, Southern Africa, and Eastern Africa have the highest incidence of esophageal squamous cell carcinoma, while the highest mortality rates occur in Middle Africa, Western Africa, and Eastern Asia. Esophageal cancer urgently requires increased research into the risk factors associated with the disease in order to develop population-based education programs and public health initiatives to reduce morbidity and mortality.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Eslick GD. Esophageal cancer: a historical perspective. Gastroenterol Clin N Am. 2009;38:1–15.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase no. 11 [internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on 12/06/2018
Simard EP, Ward EM, Siegel R, et al. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin. 2012;62(2):118–28.
Edgren G, Adami HO, Weiderpass E, et al. A global assessment of the oesophageal adenocarcinoma epidemic. Gut. 2013;62(10):1406–14.
Cook MB. Optimization and expansion of predictive models for Barrett’s esophagus and esophageal adenocarcinoma: could a life-course exposure history be beneficial? Am J Gastroenterol. 2013;108(6):923–5.
Scudiere JR, Montgomery EA. New treatments, new challenges: pathology’s perspective on esophageal carcinoma. Gastroenterol Clin N Am. 2009;38:121–33.
Arnold M, Soerjomataram I, Ferlay J, et al. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2014;64:381–7.
Hur C, Miller M, Kong CY, et al. Trends in esophageal adenocarcinoma incidence and mortality. Cancer. 2013;119(6):1149–58.
Drahos J, Wu M, Anderson WF, et al. Regional variations in esophageal cancer rates by census region in the United States, 1999–2008. PLoS One. 2013;8(7):e67913.
Kong CY, Kroep S, Curtius K, et al. Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling. Cancer Epidemiol Biomark Prev. 2014;23(6):997–1006.
Castro C, Bosetti C, Malvezzi M, et al. Patterns and trends in esophageal cancer mortality and incidence in Europe (1980-2011) and predictions to 2015. Ann Oncol. 2014;25(1):283–90.
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–32.
Giri S, Pathak R, Aryal MR, et al. Incidence trend of esophageal squamous cell carcinoma: an analysis of surveillance epidemiology, and end results (SEER) database. Cancer Causes Control. 2015;26:159–61.
Siegel R, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.
Jemal A, Simard EP, Xu J, et al. Selected cancers with increasing mortality rates by educational attainment in 26 states in the United States, 1993–2007. Cancer Causes Control. 2013;24(3):559–65.
Wong MCS, Hamilton W, Whiteman DC, Jiang JY, Qiao Y, Fung FDH, Wang HHX, Chiu PWY, Ng EKW, Wu JCY, Yu J, Chan FKL, Sung JJY. Global incidence and mortality of oesophageal cancer and their correlation with socioeconomic indicators temporal patterns and trends in 41 countries. Sci Rep. 2018;8:4522.
De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5 – a population-based study. Lancet Oncol. 2014;15(1):23–34.
Dawsey SP, Tonui S, Parker RK, et al. Esophageal cancer in young people: a case series of 109 cases and review of the literature. PLoS One. 2010;5(11):e14080.
David YN, Vignesh S, Martinez M, Mcfarlane S, Kabrawala A. Eliminating racial disparities: esophageal cancer treatment and outcomes in a va healthcare system. Gastroenterology. 2017;152(5 Supplement 1):S880–1.
Chen Z, Ren Y, Du XL, Shen Y, Li S, Wu Y, Lv M, Dong D, Li E, Li W, Liu P, Yang J, Yi M. Incidence and survival differences in esophageal cancer among ethnic groups in the United States. Oncotarget. 2017;8:47037–51.
Elliott JA, Donohoe CL, Reynolds JV. Obesity and increased risk of esophageal adenocarcinoma. Expert Rev Endocrinol Metab. 2015;10:511–23.
Turati F, Tramacere I, La Vecchia C, et al. A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma. Ann Oncol. 2013;24(3):609–17.
Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev. 2006;15(5):872–8.
Whiteman DC, Sadeghi S, Pandeya N, et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut. 2008;57(2):173–80.
Denholm M, Jankowski J. Gastroesophageal reflux disease and bulimia nervosa – a review of the literature. Dis Esophagus. 2011;24:79.
Brewster DH, Nowell SL, Clark DN. Risk of oesophageal cancer among patients previously hospitalised with eating disorder. Cancer Epidemiol. 2015;39(3):313–20.
Shaheen N, Ransohoff DF. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review. JAMA. 2002;287(15):1972–81.
Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol. 2008;103(3):788–97.
Sikkema M, de Jonge PJ, Steyerberg EW, et al. Risk of esophageal adenocarcinoma and mortality in patients with Barrett’s esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010;8(3):235–44.
Yousef F, Cardwell C, Cantwell MM, et al. The incidence of esophageal cancer and high-grade dysplasia in Barrett’s esophagus: a systematic review and meta-analysis. Am J Epidemiol. 2008;168(3):237–49.
Singh S, Manickam P, Amin AV. Incidence of esophageal adenocarcinoma in Barrett’s esophagus with low-grade dysplasia: a systematic review and meta-analysis. Gastrointest Endosc. 2014;79(6):897–909.
Jansson C, Johansson AL, Nyrén O, et al. Socioeconomic factors and risk of esophageal adenocarcinoma: a nationwide Swedish case-control study. Cancer Epidemiol Biomark Prev. 2005;14(7):1754–61.
Gammon MD, Schoenberg JB, Ahsan H, et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1997;89(17):1277–84.
Ljung R, Drefahl S, Andersson G, et al. Socio-demographic and geographical factors in esophageal and gastric cancer mortality in Sweden. PLoS One. 2013;8(4):e62067.
Jansson C, Oh JK, Martinsen JI, Lagergren J, Plato N, Kjaerheim K, Pukkala E, Sparen P, Tryggvadottir L, Weiderpass E. Occupation and risk of oesophageal adenocarcinoma and squamous-cell carcinoma: the Nordic occupational cancer study. Int J Cancer. 2015;137:590–7.
Chow WH, Mclaughlin JK, Malker HS, Linet MS, Weiner JA, Stone BJ. Esophageal cancer and occupation in a cohort of Swedish men. Am J Ind Med. 1995;27:749–57.
Tsai RJ, Luckhaupt SE, Schumacher P, Cress RD, Deapen DM, Calvert GM. Risk of cancer among firefighters in California, 1988–2007. Am J Ind Med. 2015;58:715–29.
Zhuo X, Zhang Y, Wang Y, et al. Helicobacter pylori infection and oesophageal cancer risk: association studies via evidence-based meta-analyses. Clin Oncol (R Coll Radiol). 2008;20(10):757–62.
Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res. 2008;1(5):329–38.
Andrici J, Eslick GD. Hot food and beverage consumption and the risk of esophageal cancer: a meta-analysis. Am J Prev Med. 2015;49:952–60.
IARC monographs on the evaluation of carcinogenic risks to humans. Volume 116. Drinking Coffee, Mate, and Very Hot Beverages/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, France. 2016.
Narang B, Cox MR, Eslick GD. Meat consumption and risk of developing esophageal cancer: a meta-analysis. Am J Cancer Epidemiol Prev. 2013;1:36–54.
Li B, Jiang G, Zhang G, et al. Intake of vegetables and fruit and risk of esophageal adenocarcinoma: a meta-analysis of observational studies. Eur J Nutr. 2014;53(7):1511–21.
Petrick JL, Steck SE, Bradshaw PT, Trivers KF, Abrahamson PE, Engel LS, He K, Chow WH, Mayne ST, Risch HA, Vaughan TL, Gammon MD. Dietary intake of flavonoids and oesophageal and gastric cancer: incidence and survival in the United States of America (USA). Br J Cancer. 2015;112:1291–300.
Bo Y, Sun J, Wang M, Ding J, Lu Q, Yuan L. Dietary flavonoid intake and the risk of digestive tract cancers: a systematic review and meta-analysis. Sci Rep. 2016;6:24836.
Cui L, Liu X, Tian Y, Xie C, Li Q, Cui H, Sun C. Flavonoids, flavonoid subclasses, and esophageal cancer risk: a meta-analysis of epidemiologic studies. Nutrients. 2016;8:350.
Zgaga L, O’sullivan F, Cantwell MM, Murray LJ, Thota PN, Coleman HG. Markers of vitamin D exposure and esophageal cancer risk: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev. 2016;25:877–86.
Cui J, Guo XM, Bao HL, Tan JB. Relationship between N-nitrosodimethylamine and risk of digestive tract cancers: a meta analysis based on cohort studies. Zhonghua liu xing bing xue za zhi Zhonghua liuxingbingxue zazhi. 2016;37:725–9.
Tio M, Andrici J, Cox MR, et al. Folate intake and the risk of upper gastrointestinal cancers: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2014;29:250–8.
Petrick J, Hyland PL, Carron P, Falk RT, Pfeiffer R, Dawsey SM, Abnet CC, Taylor PR, Weinstein SJ, Albanes D, Freedman ND, Guillemette C, Campbell PT, Cook MB. Association between circulating levels of sex steroid hormones and esophageal/gastric cardia adenocarcinoma. Gastroenterology. 2017;152(5 Supplement 1):S34–5.
Singh S, Garg SK, Singh PP, et al. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett’s oesophagus: a systematic review and meta-analysis. Gut. 2014;63(8):1229–37.
Andrici J, Tio M, Eslick GD. Meta-analysis: oral bisphosphonates and the risk of oesophageal cancer. Aliment Pharmacol Ther. 2012;36(8):708–16.
Abnet CC, Freedman ND, Kamangar F, et al. Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis. Br J Cancer. 2009;100(3):551–7.
Wang F, Lv ZS, Fu YK. Nonsteroidal anti-inflammatory drugs and esophageal inflammation – Barrett’s esophagus – adenocarcinoma sequence: a meta-analysis. Dis Esophagus. 2011;24(5):318–24.
Andrici J, Tio M, Eslick GD. Statin use reduces the risk of esophageal cancer: a meta-analysis. Gastroenterology. 2013;144(Suppl 1):S675.
Thomas T, Loke Y, Beales ILP. Systematic review and meta-analysis: use of statins is associated with a reduced incidence of oesophageal adenocarcinoma. J Gastrointest Canc. 2018;49(4):442–54.
Steevens J, Schouten LJ, Goldbohm RA, et al. Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut. 2010;59(1):39–48.
Tramacere I, La Vecchia C, Negri E. Tobacco smoking and esophageal and gastric cardia adenocarcinoma: a meta-analysis. Epidemiology. 2011;22(3):344–9.
Tramacere I, Pelucchi C, Bagnardi V, et al. A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk. Ann Oncol. 2012;23(2):287–97.
Freedman ND, Abnet CC, Leitzmann MF, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol. 2007;165(12):1424–33.
Lubin JH, Cook MB, Pandeya N, Vaughan TL, Abnet CC, Giffen C, Webb PM, Murray LJ, Casson AG, Risch HA, Ye W, Kamangar F, Bernstein L, Sharp L, Nyrén O, Gammon MD, Corley DA, Wu AH, Brown LM, Chow W-H, Ward MH, Freedman ND, Whiteman DC. The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett’s Esophagus and Esophageal adenocarcinoma consortium. Cancer Epidemiol. 2012;36:306–16.
Montazeri Z, Nyiraneza C, El-Katerji H, Little J. Waterpipe smoking and cancer: systematic review and meta-analysis. Tob Control. 2017;26(1):92–7.
Drahos J, Ricker W, Pfeiffer RM, Cook MB. Metabolic syndrome and risk of esophageal adenocarcinoma in elderly patients in the United States: an analysis of SEER-Medicare data. Cancer. 2017;123(4):657–65.
Dixon JL, Copeland LA, Zeber JE, Maccarthy AA, Reznik SI, Smythe WR, Rascoe PA. Association between diabetes and esophageal cancer, independent of obesity, in the United States veterans affairs population. Dis Esophagus. 2016;29(7):747–51.
Xu B, Zhou X, Li X, Liu C, Yang C. Diabetes mellitus carries a risk of esophageal cancer: a meta-analysis. Medicine. 2017;96(35):e7944.
Xie SH, Rabbani S, Petrick JL, Cook MB, Lagergren J. Racial and ethnic disparities in the incidence of esophageal cancer in the United States, 1992–2013. Am J Epidemiol. 2017;186(12):1341–51.
Prabhu A, Obi K, Lieberman D, Rubenstein JH. The race-specific incidence of esophageal squamous cell carcinoma in individuals with exposure to tobacco and alcohol. Am J Gastroenterol. 2016;111(12):1718–25.
Kim JY, Winters JK, Kim J, Bernstein L, Raz D, Gomez SL. Birthplace and esophageal cancer incidence patterns among Asian-Americans. Dis Esophagus. 2016;29(1):99–104.
Siewert JRMD, Ott KMD. Are squamous and adenocarcinomas of the esophagus the same disease? Semin Radiat Oncol. 2006;17(1):38–44.
Prabhu A, Obi KO, Rubenstein JH. The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma: a meta-analysis. Am J Gastroenterol. 2014;109(6):822–7.
Morita M, Kumashiro R, Kubo N, et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention. Int J Clin Oncol. 2010;15(2):126–34.
Islami F, Fedirko V, Tramacere I, et al. Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: a systematic review and meta-analysis. Int J Cancer. 2011;129(10):2473–84.
Prabhu A, Obi KO, Rubenstein JH. Systematic review with meta-analysis: race-specific effects of alcohol and tobacco on the risk of oesophageal squamous cell carcinoma. Aliment Pharmacol Ther. 2013;38(10):1145–55.
Bagnardi V, Rota M, Botteri E, et al. Light alcohol drinking and cancer: a meta-analysis. Ann Oncol. 2013;24(2):301–8.
Brown LM, Hoover R, Silverman D, et al. Excess incidence of squamous cell esophageal cancer among US black men: role of social class and other risk factors. Am J Epidemiol. 2001;153(2):114–22.
Dar NA, Shah IA, Bhat GA, et al. Socioeconomic status and esophageal squamous cell carcinoma risk in Kashmir. India Cancer Sci. 2013;104(9):1231–6.
Joint Iran-IARC Study Group. Esophageal cancer studies in the Caspian littoral of Iran: results of population studies – a prodrome. Joint Iran-International Agency for Research on Cancer study group. J Natl Cancer Inst. 1977;59(4):1127–38.
Dowlatshahi K, Miller RJ. Role of opium in esophageal cancer: a hypothesis. Cancer Res. 1985;45(4):1906–7.
Nasrollahzadeh D, Kamangar F, Aghcheli K, et al. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer. 2008;98(11):1857–63.
Tse G, Eslick GD. Egg consumption and risk of GI neoplasms: dose-response meta-analysis and systematic review. Eur J Nutr. 2014;53(7):1581–90.
Islami F, Ren JS, Taylor PR, et al. Pickled vegetables and the risk of oesophageal cancer: a meta-analysis. Br J Cancer. 2009;101(9):1641–7.
Zamora-Ros R, Luján-Barroso L, Bueno-de-Mesquita HB, et al. Tea and coffee consumption and risk of esophageal cancer: the European prospective investigation into cancer and nutrition study. Int J Cancer. 2014;135(6):1470–9.
Tverdal A, Hjellvik V, Selmer R. Coffee intake and oral-oesophageal cancer: follow-up of 389,624 Norwegian men and women 40–45 years. Br J Cancer. 2011;105(1):157–61.
Ren JS, Freedman ND, Kamangar F, et al. Tea, coffee, carbonated soft drinks and upper gastrointestinal tract cancer risk in a large United States prospective cohort study. Eur J Cancer. 2010;46(10):1873–81.
Boehm K, Borrelli F, Ernst E, et al. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev. 2009;3(3):CD005004. https://doi.org/10.1002/14651858.CD005004.pub2.
Hashemian M, Murphy G, Etemadi A, Poustchi H, Brockman JD, Kamangar F, Pourshams A, Khoshnia M, Gharavi A, Dawsey SM, Brennan PJ, Boffetta P, Hekmatdoost A, Malekzadeh R, Abnet CC. Toenail mineral concentration and risk of esophageal squamous cell carcinoma, results from the Golestan cohort study. Cancer Med. 2017;6(12):3052–9.
Cui J, Guo XM, Bao HL, Tan JB. Relationship between N-nitrosodimethylamine and risk of digestive tract cancers: a meta analysis based on cohort studies. [Chinese]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2016;37(5):725–9.
Kolb H, Mandrup-Poulsen T. The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia. 2010;53(1):10–20.
Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RRO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith JSC, Taubert K, Tracy RP, Vinicor F, Centers for Disease, C, Prevention, American Heart, A. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499–511.
Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29(1):415–45.
Shivappa N, Zucchetto A, Serraino D, Rossi M, La Vecchia C, Hebert JR. Dietary inflammatory index and risk of esophageal squamous cell cancer in a case-control study from Italy. Cancer Causes Control. 2015;26(10):1439–47.
Lu Y, Shivappa N, Lin Y, Lagergren J, Hebert JR. Diet-related inflammation and oesophageal cancer by histological type: a nationwide case-control study in Sweden. Eur J Nutr. 2016;55(4):1683–94.
Andrici J, Eslick GD. Maté consumption and the risk of esophageal squamous cell carcinoma: a meta-analysis. Dis Esophagus. 2013;26(8):807–16.
Dar NA, Islami F, Bhat GA, et al. Poor oral hygiene and risk of esophageal squamous cell carcinoma in Kashmir. Br J Cancer. 2013;109(5):1367–72.
Abnet CC, Qiao YL, Mark SD, et al. Prospective study of tooth loss and incident esophageal and gastric cancers in China. Cancer Causes Control. 2001;12(9):847–54.
Abnet CC, Kamangar F, Islami F, et al. Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomark Prev. 2008;17(11):3062–8.
Guha N, Boffetta P, Wünsch Filho V, et al. Oral health and risk of squamous cell carcinoma of the head and neck and esophagus: results of two multicentric case-control studies. Am J Epidemiol. 2007;166(10):1159–73.
Hiraki A, Matsuo K, Suzuki T, Kawase T, et al. Teeth loss and risk of cancer at 14 common sites in Japanese. Cancer Epidemiol Biomark Prev. 2008;17(5):1222–7.
Abnet CC, Kamangar F, Dawsey SM, et al. Tooth loss is associated with increased risk of gastric non-cardia adenocarcinoma in a cohort of Finnish smokers. Scand J Gastroenterol. 2005;40(6):681–7.
Ljung R, Martin L, Lagergren J. Oral disease and risk of oesophageal and gastric cancer in a nationwide nested case-control study in Sweden. Eur J Cancer. 2011;47(14):2128–32.
Lee KD, Wang TY, Lu CH, Huang CE, Chen MC. The bidirectional association between oral cancer and esophageal cancer: a population-based study in Taiwan over a 28-year period. Oncotarget. 2017;8(27):44567–78.
Saedi B, Razmpa E, Ghalandarabadi M, Ghadimi H, Saghafi F, Naseri M. Epidemiology of oral cavity cancers in a country located in the esophageal cancer belt: a case control study. Iran J Otorhinolaryngol. 2012;24(68):113–8.
Shakeri R, Kamangar F, Nasrollahzadeh D, Nouraie M, Khademi H, Etemadi A, Islami F, Marjani H, Fahimi S, Sepehr A, Rahmati A, Abnet CC, Dawsey SM, Brennan P, Boffetta P, Malekzadeh R, Majdzadeh R. Is opium a real risk factor for esophageal cancer or just a methodological artifact? Hospital and neighborhood controls in case-control studies. PLoS One. 2012;7(3):e32711.
Kayamba V, Bateman AC, Asombang AW, Shibemba A, Zyambo K, Banda T, Soko R, Kelly P. HIV infection and domestic smoke exposure, but not human papillomavirus, are risk factors for esophageal squamous cell carcinoma in Zambia: a case-control study. Cancer Med. 2015;4(4):588–95.
Halec G, Schmitt M, Egger S, Abnet CC, Babb C, Dawsey SM, Flechtenmacher C, Gheit T, Hale M, Holzinger D, Malekzadeh R, Taylor PR, Tommasino M, Urban MI, Waterboer T, Pawlita M, Sitas F. Mucosal alpha-papillomaviruses are not associated with esophageal squamous cell carcinomas: lack of mechanistic evidence from South Africa, China and Iran and from a world-wide meta-analysis. Int J Cancer. 2016;139(1):85–98.
Liyanage SS, Rahman B, Ridda I, Newall AT, Tabrizi SN, Garland SM, Segelov E, Seale H, Crowe PJ, Moa A, Macintyre CR. The aetiological role of human papillomavirus in oesophageal squamous cell carcinoma: a meta-analysis. PLoS One. 2013;8(7):e69238.
Rokkas T, Pistiolas D, Sechopoulos P, et al. Relationship between helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol. 2007;5(12):1413–7.
Eitzen K, Eslick GD, Cox MR. Helicobacter pylori cag-a positivity – an important determinant for esophageal squamous cell carcinoma risk: a systemtic review and meta-analysis. J Gastroenterol Hepatol. 2011;26(Suppl 4):81–2.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Vijayan, K., Eslick, G.D. (2020). Epidemiology and Risk Factors for Esophageal Cancer. In: Saba, N., El-Rayes, B. (eds) Esophageal Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-29832-6_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-29832-6_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-29831-9
Online ISBN: 978-3-030-29832-6
eBook Packages: MedicineMedicine (R0)